Encompass Health Corporation (EHC) Balance Sheet

The balance sheet is clearly strengthening, driven by robust retained earnings accumulation and modest asset growth. Equity has grown from $1.7B to $2.6B, a 53% increase, while total liabilities have remained relatively flat, suggesting that the company is funding its expansion through internal cash generation rather than excessive debt. This trend implies improving financial flexibility and a reduced reliance on external financing, which is a positive signal for business quality.

The company has been steadily reducing leverage, with D/E falling from 1.21 in 2024Q1 to 0.82 in 2026Q2, while total debt has remained roughly constant at $2.8B. This suggests that the company is not taking on additional debt to fund its capital expenditure program, which is a positive sign for debt sustainability. The stable debt level combined with growing equity indicates that the company is generating sufficient cash flow to fund its expansion, reducing refinancing risk and enhancing cash flow durability.

The asset mix is heavily weighted toward property, plant, and equipment, which now constitutes 60% of total assets, up from 58% a year ago. This reflects the company's strategy of investing in de novo hospitals and bed expansions, which is consistent with its capital-intensive business model. Goodwill has remained stable at $1.3B, suggesting no major acquisitions and reducing the risk of impairment. The increasing PPE investment signals confidence in future demand for inpatient rehabilitation services, but also implies higher fixed costs and depreciation, which could pressure margins if occupancy rates do not improve.

The equity base has expanded significantly, almost entirely due to retained earnings, which have more than tripled. This indicates that the company is reinvesting its profits into the business and maintaining a conservative payout policy, which strengthens the equity cushion. The lack of significant dilution or share issuance suggests that the company is not relying on equity financing, which is a positive signal for existing shareholders. However, the company has been increasing share repurchases, which could offset some of the equity growth, but the overall trend remains positive.

The current ratio has improved from 1.05 to 1.19 over the past year, indicating better short-term liquidity. However, cash balances are relatively low, averaging around $100-200M, which is modest for a company with $7.5B in assets. This suggests that the company is efficiently deploying its cash into capital expenditures and debt reduction, but it also leaves a thin buffer against unexpected shocks. The improving current ratio is a positive sign, but investors should monitor whether the company maintains adequate liquidity to support its expansion plans.